Mitomycin C and High-Dose 5-Fluorouracil With Folinic Acid as a Therapeutic Option for Heavily Pretreated Patients With Metastatic Colorectal Cancer: Prospective Phase II Trial

Por Stec, Rafał, Bodnar, Lubomir, Smoter, Marta, Korniluk, Jan, Kuchar, Agata, Młot, Beata, Szczylik, Cezary
Publicado em 2014

Prolonged complete response following gemcitabine-erlotinib combined therapy in advanced pancreatic cancer

Por CZARNECKA, ANNA M., KORZEŃ, PIOTR, NOWAK-DEMENT, ANNA, KUKWA, WOJCIECH, KORNILUK, JAN, SZCZYLIK, CEZARY
Publicado no Oncol Lett (2016)

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer

Por STEC, RAFAŁ, SEMENIUK-WOJTAŚ, ALEKSANDRA, CHARKIEWICZ, RADOSŁAW, BODNAR, LUBOMIR, KORNILUK, JAN, SMOTER, MARTA, CHYCZEWSKI, LECH, NIKLIŃSKI, JACEK, SZCZYLIK, CEZARY
Publicado no Oncol Lett (2015)

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

Por Stec, Rafał, Bodnar, Lubomir, Charkiewicz, Radosław, Korniluk, Jan, Rokita, Marta, Smoter, Marta, Ciechowicz, Marzena, Chyczewski, Lech, Nikliński, Jacek, Kozłowski, Wojciech, Szczylik, Cezary
Publicado em 2012

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system

Por Rokita, Marta, Stec, Rafał, Bodnar, Lubomir, Charkiewicz, Radosław, Korniluk, Jan, Smoter, Marta, Cichowicz, Marzena, Chyczewski, Lech, Nikliński, Jacek, Kozłowski, Wojciech, Szczylik, Cezary
Publicado em 2013